citalopram and reboxetine

citalopram has been researched along with reboxetine in 97 studies

Research

Studies (97)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	44 (45.36)	29.6817
2010's	48 (49.48)	24.3611
2020's	5 (5.15)	2.80

Authors

Authors	Studies
Devarajan, S; Dursun, SM	2
Hinkka, S; Kuusela, T; Penttilä, J; Scheinin, H; Syvälahti, E	1
Auclair, A; Gobert, A; Lejeune, F; Millan, MJ; Newman-Tancredi, A; Peglion, JL; Rivet, JM	1
Brocco, M; Dekeyne, A; La Rochelle, CD; MacSweeny, C; Millan, MJ; Papp, M; Peglion, JL	1
Bond, AJ; Tse, WS	1
Bhagwagar, Z; Cowen, PJ; Harmer, CJ; Shelley, N	1
Mohr, N; Muller, JE; Seedat, S; Stein, DJ; van Rheede van Oudtshoorn, E	1
Holoubek, G; Müller, WE	1
Alvano, A; Chiechio, S; Malaguarnera, M; Nicoletti, G; Raffaele, R; Rampello, L; Vecchio, I	1
Elger, CE; Falkai, P; Kühn, KU; Maier, W; Quednow, BB; Thiel, M	1
Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA	1
Alejandre, H; Chen, MJ; Garcia, C; Ivy, AS; Russo-Neustadt, AA	1
Cowen, PJ; Goodwin, GM; Harmer, CJ; Shelley, NC	1
Frodl, T; Hegerl, U; Henkel, V; Juckel, G; Mergl, R; Müller-Siecheneder, F; Pogarell, O	1
Arolt, V; Erfurth, A; Evers, S; Hetzel, G; Moeller, O; Ponath, G; Rothermundt, M	1
Arolt, V; Erfurth, A; Evers, S; Hetzel, G; Michael, N; Moeller, O; Rothermundt, M	1
Camarasa, X; Duboc, A; Khazaal, Y; Lopez-Martinez, E; Zullino, DF	1
Aragona, M; Bancheri, L; Conte, A; Inghilleri, M; Perinelli, D; Pizzimenti, A; Tarsitani, L	1
Arolt, V; Erfurth, A; Hetzel, G; Michael, N; Moeller, O; Rothermundt, M	1
Fontenelle, LF; Mendlowicz, MV; Miguel, EC; Versiani, M	1
Amann, B; Hegerl, U; Juckel, G; Mergl, R; Mulert, C; Padberg, F; Pogarell, O; Sterr, A	1
Agren, H; Bodlund, O; Langworth, S	1
Inoue, T; Izumi, T; Kitaichi, Y; Koyama, T; Nakagawa, S	1
Berlanga, C; Flores-Ramos, M	1
Brand, L; Daniels, W; Hugo, C; Marais, L; Stein, DJ; Viljoen, F	1
Brunnmeier, M; Hegerl, U; Juckel, G; Karch, S; Leicht, G; Mergl, R; Möller, HJ; Mulert, C; Pogarell, O	1
Castrén, E; Chao, MV; Domenici, E; Hendolin, P; Kankaanpää, A; Männistö, PT; Mijatovic, J; Piepponen, P; Rantamäki, T	1
Bechtholt, AJ; Crowley, JJ; Hill, TE; Lucki, I; O'Leary, OF; Page, ME	1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J	1
Augustin, H; Frodl, T; Hegerl, U; Juckel, G; Mavrogiorgou, P; Mulert, C; Müller-Siecheneder, F; Pogarell, O	1
Cowen, PJ; Evans, J; Jezzard, P; Murphy, SE; Selvaraj, S; Taylor, M; Wylezinkska, M	1
Gallwitz, T; Kirch, MH; Messer, T; Rottach, KG; Schaner, BM; Teufel, LM; Zivotofsky, AZ	1
Akar, FY; Erden, BF; Komsuoğlu, FI; Mutlu, O; Tanyeri, P; Ulak, G	1
Itakura, C; Katayama, M; Niimi, K; Takahashi, E	1
Andreasen, JT; Olsen, GM; Redrobe, JP; Wiborg, O	1
Cowen, PJ; Harmer, CJ; Lester, KJ; Murphy, SE; Yiend, J	1
Andreasen, JT; Redrobe, JP	1
Bhagwagar, Z; Croft, RJ; Kerestes, R; Labuschagne, I; Nathan, PJ; O'Neill, BV; Phan, KL	1
Blicharska, E; Brański, P; Cichy, A; Dybała, M; Nowak, G; Pilc, A; Piotrowska, A; Poleszak, E; Pomierny-Chamioło, L; Siwek, A; Szewczyk, B; Wlaź, P; Wróbel, A	1
Assem-Hilger, E; Kasper, S; Konstantinidis, A; Pjrek, E; Praschak-Rieder, N; Willeit, M; Winkler, D	1
Anderson, IM; Bell, D; Gutting, P; Harmer, C; Healy, D; Tranter, R	1
Alejandre, H; Arunrut, T; Cha, J; Chen, M; Russo-Neustadt, A	1
Linka, T; Müller, BW; Sartory, G; Wiltfang, J	1
Brühl, AB; Herwig, U; Kaffenberger, T	1
Cowen, PJ; Harmer, CJ; McCabe, C; Mishor, Z	1
Cremers, TI; Folgering, J; Rea, K; Westerink, BH	1
Andreasen, JT; Christensen, JK; Mirza, NR; Nielsen, EØ; Olsen, GM; Peters, D; Redrobe, JP	1
Brański, P; Lenda, T; Pałucha-Poniewiera, A; Pilc, A	1
Croft, RJ; Leung, S; Nathan, PJ; O'Kane, J; O'Neill, BV; Oliva, J; Phan, KL; Stout, J	1
Koch, K; Reichenbach, JR; Sauer, H; Schachtzabel, C; Schlösser, RG; Sobanski, T; Wagner, G	1
Callado, LF; Fernández-Pastor, B; Meana, JJ; Ortega, JE	1
Choi, SH; Kang, S; Kim, HJ; Lee, MS; Shin, KH; Shin, SK	1
Fisar, Z; Hroudová, J; Raboch, J	1
Cowen, P; Craddock, N; Grozeva, D; Ikeda, M; Lewis, G; Mason, V; Mulligan, J; Nutt, D; O'Donovan, MC; Peters, TJ; Sharp, D; Tallon, D; Thomas, L; Wiles, N	1
Aldenhoff, J; Göder, R; Huchzermeier, C; Koch, J; Kropp, C; Palaschewski, M; Seeck-Hirschner, M; Stingele, K	1
Bert, B; Fink, H; Günther, L; Millan, MJ; Rex, A; Rothe, J; Voigt, JP	1
McCabe, C; Mishor, Z	1
Arteche, A; Craske, MG; Harmer, C; Harvey, A; Lehtonen, A; Murphy, S; Stein, A	1
Aryal, DK; Deng, JV; Hutchinson, AN; West, AE; Wetsel, WC	1
Bevins, RA; Dion, AM; Murrin, LC; Sanderson, SC	1
Chapman, A; Delivuk, M; Gartlehner, G; Gaynes, BN; Kaminski, A; Thaler, K	1
Cowen, PJ; Lewis, G; Mason, V; Mulligan, J; Nutt, D; O'Donovan, MC; Peters, TJ; Sharp, D; Tallon, D; Thomas, L; Wiles, NJ	1
Bould, H; Cowen, P; Lewis, G; Nutt, DJ; Peters, TJ; Potokar, J; Wiles, N	1
Clinckers, R; Massie, A; Smolders, I; Vermoesen, K	1
Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N	1
Eriksson, AC; Hägg, S; Hallbäck, I; Whiss, PA	1
Młyniec, K; Nowak, G	2
Álvarez-Cervera, FJ; Flores-Serrano, AG; Góngora-Alfaro, JL; Heredia-López, FJ; Pineda, JC; Vila-Luna, ML	1
Hinkelmann, K; Jahn, H; Kellner, M; Raedler, TJ; Wiedemann, K; Yassouridis, A	1
Barak, Y; Baratz-Goldstein, R; Hostovsky, A; Pick, CG; Rubovitch, V; Schreiber, S; Volis, I	1
Nowak, G; Pilc, A; Poleszak, E; Popik, P; Siwek, A; Szewczyk, B; Wolak, M	1
Cadeddu, R; Carboni, E; Ibba, M; Sadile, A	1
Cowen, P; Crawford, AA; Lewis, G; Lewis, S; Nutt, D; O'Donovan, MC; Peters, TJ; Wiles, N	1
Niedzielska, E; Nowak, G; Pałucha-Poniewiera, A; Pilc, A; Pomierny, B; Pomierny-Chamioło, L; Siwek, A	1
Button, KS; Crawford, A; Green, A; Lewis, G; Nutt, D; Peters, TJ; Wiles, N	1
Bernardo, M; Caballero, M; Corripio, I; Felipe, AE; Fernandez de Corres, B; González Piqueras, JC; Huerta, R; Ibáñez, A; Iniesta, R; López-Carrilero, R; Oliveira, C; Roca, M; Rodriguez-Jimenez, R; Sindreu, SD; Usall, J	1
Cowen, P; Fischer, K; Lewis, G; Nutt, D; Peters, TJ; White, IR; Wiles, NJ	1
Callado, LF; Díez-Alarcia, R; González-Maeso, J; Meana, JJ; Miranda-Azpiazu, P; Morentin, B; Muguruza, C	1
Krakowska, A; Mlyniec, K; Nowak, G; Opoka, W; Ostachowicz, B; Reczynski, W	1
Gaweł, M; Młyniec, K; Nowak, G	1
Dong, C; Han, M; Hashimoto, K; Ma, M; Ren, Q; Saito, R; Yang, C; Yao, W; Zhang, JC	1
Fendt, M; Leibiger, J; Schmidt, C	1
Lenda, T; Pałucha-Poniewiera, A; Pilc, A; Podkowa, K	1
Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C	1
Horder, J; Matthews, PRL; Pearce, M	1
De Simone, A; Höfner, G; Neiens, P; Wanner, KT	1
Allmendinger, L; De Simone, A; Höfner, G; Neiens, P; Ramershoven, A; Wanner, KT	1
Bogatko, K; Doboszewska, U; Dudka, J; Poleszak, E; Serefko, A; Świąder, K; Szopa, A; Wlaź, A; Wlaź, P; Wośko, S; Wróbel, A; Wyska, E	1
Cui, R; Li, X; Liu, L; Ruan, H; Wang, L	1
Buchanan, GF; Dayton, KG; Kruse, SW; Purnell, BS; Rosner, JI	1
Gougoulaki, M; Lewis, G; Nutt, DJ; Peters, TJ; Wiles, NJ	1
Chapman, A; Gartlehner, G; Gaynes, BN; Nussbaumer-Streit, B; Probst, T; Sönnichsen, A; Thaler, K; Winkler, D	1
Chmielarz, P; Chorązka, K; Kowalska, M; Kuśmierczyk, J; Nalepa, I; Rafa-Zabłocka, K; Satała, G	1
Christoffersen, T; Klarskov, N; Kornholt, J; Riis, T; Sonne, DP; Sonne, J	1
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K	1

Reviews

6 review(s) available for citalopram and reboxetine

Article	Year
Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Journal of psychiatric research, 2009, Volume: 43, Issue:8 Topics: Adrenergic Uptake Inhibitors; Citalopram; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome	2009
Second-generation antidepressants for seasonal affective disorder. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Phototherapy; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes	2011
Citalopram versus other anti-depressive agents for depression. The Cochrane database of systematic reviews, 2012, Jul-11, Issue:7 Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2012
Selective noradrenaline reuptake inhibitors for schizophrenia. The Cochrane database of systematic reviews, 2018, Jan-25, Volume: 1 Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Citalopram; Cognition; Humans; Morpholines; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Schizophrenia; Serotonin and Noradrenaline Reuptake Inhibitors; Viloxazine	2018
Second-generation antidepressants for treatment of seasonal affective disorder. The Cochrane database of systematic reviews, 2021, 03-04, Volume: 3 Topics: Adult; Antidepressive Agents, Second-Generation; Bias; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Observational Studies as Topic; Phototherapy; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes; Treatment Outcome	2021
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Molecular psychiatry, 2023, Volume: 28, Issue:1 Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine	2023

Trials

36 trial(s) available for citalopram and reboxetine

Article	Year
Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms. Psychopharmacology, 2001, Volume: 153, Issue:4 Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Venlafaxine Hydrochloride	2001
The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers. Psychopharmacology, 2001, Volume: 154, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Analysis of Variance; Autonomic Nervous System; Blood Pressure; Catecholamines; Citalopram; Cross-Over Studies; Double-Blind Method; Heart Rate; Humans; Linear Models; Male; Morpholines; Reboxetine; Salivation; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric	2001
Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology, 2002, Volume: 159, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Citalopram; Cooperative Behavior; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Social Behavior; Speech	2002
Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology, 2003, Volume: 167, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Circadian Rhythm; Citalopram; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Morpholines; Pituitary-Adrenal System; Reboxetine; Saliva; Selective Serotonin Reuptake Inhibitors; Wakefulness	2003
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study. International clinical psychopharmacology, 2003, Volume: 18, Issue:5 Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Citalopram; Comorbidity; Cross-Over Studies; Depression; Female; Humans; Male; Middle Aged; Morpholines; Panic Disorder; Pilot Projects; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome	2003
Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology, 2004, Volume: 173, Issue:1-2 Topics: Adrenergic Uptake Inhibitors; Aged; Analysis of Variance; Case-Control Studies; Citalopram; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Morpholines; Predictive Value of Tests; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Stroke; Treatment Outcome	2004
Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy & behavior : E&B, 2003, Volume: 4, Issue:6 Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Chi-Square Distribution; Citalopram; Demography; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Interactions; Electroencephalography; Epilepsy, Temporal Lobe; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Patient Dropouts; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Reboxetine; Time Factors	2003
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. The American journal of psychiatry, 2004, Volume: 161, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anger; Anxiety Disorders; Citalopram; Cognition; Depressive Disorder; Double-Blind Method; Facial Expression; Fear; Female; Hostility; Humans; Male; Memory; Morpholines; Placebos; Reboxetine; Recognition, Psychology; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Social Perception; Surveys and Questionnaires; Visual Perception	2004
The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology, 2005, Volume: 178, Issue:2-3 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Astrocytes; Citalopram; Depressive Disorder, Major; Electroencephalography; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Morpholines; Nerve Growth Factors; Neurons; Personality Inventory; Psychometrics; Reaction Time; Reboxetine; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Selective Serotonin Reuptake Inhibitors; Signal Processing, Computer-Assisted; Statistics as Topic	2005
The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Citalopram; Depressive Disorder, Major; Electrooculography; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Morpholines; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors	2004
Escitalopram/reboxetine combination in depressed patients with substance use disorder. Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1 Topics: Adult; Alcoholism; Antidepressive Agents; Bipolar Disorder; Citalopram; Depressive Disorder, Major; Diagnosis, Dual (Psychiatry); Drug Combinations; Female; Humans; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Substance-Related Disorders	2005
Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. European journal of pain (London, England), 2005, Volume: 9, Issue:1 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Analgesics; Central Nervous System; Citalopram; Depressive Disorder; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Pain Measurement; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Somatoform Disorders; Treatment Outcome	2005
Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram. Neuropsychobiology, 2005, Volume: 51, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Morpholines; Prolactin; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors	2005
Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Morpholines; Patient Dropouts; Psychiatric Status Rating Scales; Reboxetine; Sexual Dysfunction, Physiological; Xerostomia	2006
Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. Journal of affective disorders, 2006, Volume: 95, Issue:1-3 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Citalopram; Depressive Disorder; Double-Blind Method; Female; Gonadal Hormones; Humans; Male; Morpholines; Premenopause; Reboxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors	2006
Motor cortex excitability after vagus nerve stimulation in major depression. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2 Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid	2007
Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. The Journal of clinical psychiatry, 2007, Volume: 68, Issue:8 Topics: Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Evoked Potentials, Auditory; Female; Humans; Male; Morpholines; Prospective Studies; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2007
Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy. Journal of psychopharmacology (Oxford, England), 2008, Volume: 22, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Double-Blind Method; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Morpholines; Occipital Lobe; Reboxetine; Selective Serotonin Reuptake Inhibitors; Young Adult	2008
Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. The international journal of neuropsychopharmacology, 2009, Volume: 12, Issue:2 Topics: Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Anxiety; Attention; Citalopram; Decision Making; Double-Blind Method; Female; Humans; Male; Morpholines; Neuropsychological Tests; Reaction Time; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Young Adult	2009
Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study. Psychopharmacology, 2009, Volume: 202, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Citalopram; Cross-Over Studies; Double-Blind Method; Electroencephalography; Emotions; Evoked Potentials; Facial Expression; Female; Humans; Male; Morpholines; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Social Perception; Young Adult	2009
The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. Journal of affective disorders, 2009, Volume: 118, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Emotions; Facial Expression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Pattern Recognition, Visual; Reboxetine; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2009
Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2 Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain; Brain Mapping; Citalopram; Expressed Emotion; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Morpholines; Neural Pathways; Norepinephrine; Oxygen; Photic Stimulation; Reboxetine; Serotonin; Single-Blind Method; Young Adult	2010
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biological psychiatry, 2010, Mar-01, Volume: 67, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anxiety Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Morpholines; Nerve Net; Reboxetine; Reward; Selective Serotonin Reuptake Inhibitors; Young Adult	2010
The loudness dependence auditory evoked potential is insensitive to acute changes in serotonergic and noradrenergic neurotransmission. Human psychopharmacology, 2010, Volume: 25, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Citalopram; Double-Blind Method; Electrophysiological Phenomena; Evoked Potentials, Auditory; Female; Humans; Loudness Perception; Male; Morpholines; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Young Adult	2010
Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. The British journal of psychiatry : the journal of mental science, 2011, Volume: 198, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Homozygote; Humans; Life Change Events; Male; Middle Aged; Morpholines; Polymerase Chain Reaction; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Reboxetine; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; United Kingdom; Young Adult	2011
Sleep and cognition at baseline and the effects of REM sleep diminution after 1 week of antidepressive treatment in patients with depression. Journal of sleep research, 2011, Volume: 20, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Cognition; Depressive Disorder; Female; Humans; Male; Memory; Morpholines; Neuropsychological Tests; Polysomnography; Reboxetine; Sleep; Sleep, REM; Young Adult	2011
Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. NeuroImage, 2011, Aug-15, Volume: 57, Issue:4 Topics: Adult; Antidepressive Agents; Cerebral Cortex; Citalopram; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Morpholines; Neural Pathways; Reboxetine; Rest	2011
Effects of reboxetine and citalopram on appraisal of infant facial expressions and attentional biases. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:5 Topics: Attention; Citalopram; Depression, Postpartum; Double-Blind Method; Emotions; Facial Expression; Female; Humans; Male; Morpholines; Mother-Child Relations; Reboxetine; Young Adult	2012
Severity of depression and response to antidepressants: GENPOD randomised controlled trial. The British journal of psychiatry : the journal of mental science, 2012, Volume: 200, Issue:2 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Citalopram; Depressive Disorder; Female; Humans; Intention to Treat Analysis; International Classification of Diseases; Linear Models; Male; Middle Aged; Morpholines; Primary Health Care; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; United Kingdom; Young Adult	2012
Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:5 Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Fatigue; Female; Follow-Up Studies; Humans; Male; Morpholines; Reboxetine; Severity of Illness Index; Treatment Outcome	2012
No effects of antidepressants on negative symptoms in schizophrenia. Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Chi-Square Distribution; Citalopram; Double-Blind Method; Drug Therapy, Combination; Female; Germany; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome	2013
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals. Psychopharmacology, 2014, Volume: 231, Issue:15 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dizziness; Female; Follow-Up Studies; Humans; Male; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Refusal	2014
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Citalopram; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Olanzapine; Psychiatric Status Rating Scales; Reboxetine; Risperidone; Schizophrenia; Schizophrenic Psychology	2014
Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial. Psychological medicine, 2014, Volume: 44, Issue:13 Topics: Adult; Citalopram; Data Interpretation, Statistical; Female; Humans; Male; Medication Adherence; Middle Aged; Morpholines; Neurotransmitter Uptake Inhibitors; Randomized Controlled Trials as Topic; Reboxetine; Treatment Outcome	2014
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:8 Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Depression; Female; Humans; Male; Menopause; Middle Aged; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sex Factors; Treatment Outcome	2021
Effect of single doses of citalopram and reboxetine on urethral pressure: A randomized, double-blind, placebo- and active-controlled three-period crossover study in healthy women. Neurourology and urodynamics, 2022, Volume: 41, Issue:6 Topics: Citalopram; Cross-Over Studies; Double-Blind Method; Female; Humans; Reboxetine; Selective Serotonin Reuptake Inhibitors; Urethra; Urinary Incontinence, Stress	2022

Other Studies

55 other study(ies) available for citalopram and reboxetine

Article	Year
Citalopram plus reboxetine in treatment-resistant depression. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2000, Volume: 45, Issue:5 Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2000
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:2 Topics: Animals; Brain Chemistry; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Electrophysiology; Humans; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride	2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. The Journal of pharmacology and experimental therapeutics, 2001, Volume: 298, Issue:2 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Carrier Proteins; Citalopram; Clomipramine; Cyclohexanols; Discrimination, Psychological; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Morpholines; Nerve Tissue Proteins; Norepinephrine Plasma Membrane Transport Proteins; p-Chloroamphetamine; Postural Balance; Rats; Rats, Wistar; Reaction Time; Reboxetine; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride	2001
Specific modulation of sigma binding sites by the anxiolytic drug opipramol. Journal of neural transmission (Vienna, Austria : 1996), 2003, Volume: 110, Issue:10 Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain; Cell Membrane; Citalopram; Imipramine; Male; Morpholines; Opipramol; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta; Receptors, Serotonin, 5-HT2; Receptors, sigma; Swimming	2003
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proceedings of the National Academy of Sciences of the United States of America, 2004, May-25, Volume: 101, Issue:21 Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail	2004
Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:12 Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Gene Expression Regulation; Hippocampus; In Situ Hybridization; Male; Morpholines; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Time Factors	2004
Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology, 2005, Volume: 178, Issue:1 Topics: Acute Disease; Adrenergic Uptake Inhibitors; Adult; Biomechanical Phenomena; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Hand; Handwriting; Humans; Male; Morpholines; Movement; Psychomotor Performance; Reboxetine; Selective Serotonin Reuptake Inhibitors	2005
Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2005, Volume: 6, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Citalopram; Drug Resistance; Drug Therapy, Combination; Humans; Male; Morpholines; Obsessive-Compulsive Disorder; Reboxetine; Secondary Prevention; Selective Serotonin Reuptake Inhibitors	2005
Electroencephalographic abnormalities associated with antidepressant treatment: a comparison of mirtazapine, venlafaxine, citalopram, reboxetine, and amitriptyline. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:2 Topics: Adult; Amitriptyline; Antidepressive Agents; Cerebral Cortex; Citalopram; Cyclohexanols; Electroencephalography; Epilepsy; Female; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Morpholines; Reboxetine; Venlafaxine Hydrochloride	2006
Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing. European journal of pharmacology, 2006, Jul-01, Volume: 540, Issue:1-3 Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Fear; Male; Morpholines; Norepinephrine; Rats; Rats, Sprague-Dawley; Reboxetine; Selective Serotonin Reuptake Inhibitors	2006
Psychopharmacology of maternal separation anxiety in vervet monkeys. Metabolic brain disease, 2006, Volume: 21, Issue:2-3 Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety, Separation; Behavior, Animal; Biogenic Monoamines; Chlorocebus aethiops; Citalopram; Excitatory Amino Acid Antagonists; Female; Lamotrigine; Male; Maternal Deprivation; Morpholines; Motor Activity; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior; Triazines	2006
Prediction of treatment response in major depression: integration of concepts. Journal of affective disorders, 2007, Volume: 98, Issue:3 Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Electroencephalography; Equipment Design; Evoked Potentials, Auditory; Female; Gyrus Cinguli; Humans; Male; Middle Aged; Morpholines; Neurophysiology; Prospective Studies; Reboxetine; Sleep Deprivation; Theta Rhythm	2007
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:10 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Binding Sites; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Citalopram; Cyclic AMP Response Element-Binding Protein; Depressive Disorder; Gyrus Cinguli; Hippocampus; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Phospholipase C gamma; Phosphorylation; Reboxetine; Receptor, trkB; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Up-Regulation	2007
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology, 2007, Volume: 192, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Brain; Citalopram; Desipramine; Dopamine; Fenclonine; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Morpholines; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin	2007
Restless legs syndrome as side effect of second generation antidepressants. Journal of psychiatric research, 2008, Volume: 43, Issue:1 Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prospective Studies; Reboxetine; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors	2008
Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats. Pharmacology, biochemistry, and behavior, 2008, Volume: 90, Issue:4 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Drug Interactions; Enzyme Inhibitors; Fluoxetine; Imidazoles; Male; Morpholines; Motor Activity; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Thiazepines	2008
Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests. European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Mice, Inbred CBA; Models, Animal; Morpholines; Motor Activity; Nomifensine; Piperidines; Pyrazoles; Reboxetine; Receptor, Cannabinoid, CB1; Rimonabant; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming	2008
Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. Journal of psychopharmacology (Oxford, England), 2009, Volume: 23, Issue:7 Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Female; Mice; Mice, Inbred Strains; Morpholines; Motor Activity; Nicotinic Agonists; Nicotinic Antagonists; Reboxetine	2009
Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behavioural brain research, 2009, Jan-30, Volume: 197, Issue:1 Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Mecamylamine; Mice; Morpholines; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Norepinephrine; Reboxetine; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Serotonin	2009
The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test. Progress in neuro-psychopharmacology & biological psychiatry, 2009, Mar-17, Volume: 33, Issue:2 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Aspartic Acid; Citalopram; Fenclonine; Fluoxetine; Male; Mice; Morpholines; Motor Activity; Organometallic Compounds; Piperazines; Pyridines; Rats; Rats, Wistar; Reboxetine; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Swimming; Zinc Compounds	2009
Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Life sciences, 2009, Apr-24, Volume: 84, Issue:17-18 Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; In Situ Hybridization; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Swimming	2009
Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. Neuroscience letters, 2009, Sep-29, Volume: 463, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Evoked Potentials, Auditory; Female; Humans; Male; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors	2009
Alpha1-adrenoceptors modulate citalopram-induced serotonin release. Neuropharmacology, 2010, Volume: 58, Issue:7 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Brain; Citalopram; Extracellular Space; Hippocampus; Imidazoles; Male; Morpholines; Prazosin; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Wistar; Reboxetine; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Serotonin	2010
Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test. Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:10 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Azepines; Benzamides; Bridged Bicyclo Compounds; Citalopram; Female; Male; Mice; Morpholines; Motor Activity; Nicotinic Agonists; Pyridines; Rats; Rats, Wistar; Reboxetine; Receptors, Nicotinic; Swimming; Xenopus laevis	2011
The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. The Journal of pharmacology and experimental therapeutics, 2010, Sep-01, Volume: 334, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Benzhydryl Compounds; Citalopram; Fenclonine; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Metabotropic Glutamate; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Swimming	2010
Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. Journal of psychiatry & neuroscience : JPN, 2010, Volume: 35, Issue:4 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Analysis of Variance; Brain; Citalopram; Cognition; Depressive Disorder; Electroencephalography; Evoked Potentials; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Morpholines; Neuropsychological Tests; Oxygen; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychomotor Performance; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult	2010
In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:11 Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Brain; Citalopram; Drug Synergism; Extracellular Space; Locus Coeruleus; Male; Morpholines; Norepinephrine; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Reboxetine	2010
Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test. European journal of pharmacology, 2010, Nov-25, Volume: 647, Issue:1-3 Topics: Adrenergic Uptake Inhibitors; Amphetamine; Amygdala; Animals; Behavior, Animal; Citalopram; Cocaine; Corticosterone; Dopamine Uptake Inhibitors; Locus Coeruleus; Male; Morpholines; Nerve Tissue Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Swimming	2010
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro endocrinology letters, 2010, Volume: 31, Issue:5 Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride	2010
5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test. Neuropharmacology, 2011, Volume: 61, Issue:3 Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Cerebral Cortex; Citalopram; Depression; Female; Limbic System; Male; Mice; Mice, Transgenic; Morpholines; Motor Activity; Nerve Tissue Proteins; Neurons; Organ Specificity; Reboxetine; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Sex Characteristics	2011
Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:2 Topics: Animals; Brain; Cells, Cultured; Citalopram; Colforsin; Dopamine; Dopamine Agonists; Drug Interactions; GABAergic Neurons; Gene Expression Regulation; Male; Methyl-CpG-Binding Protein 2; Mice; Mice, Knockout; Microinjections; Molecular Imaging; Morpholines; Motor Activity; Phosphorylation; Piperazines; Plasma Membrane Neurotransmitter Transport Proteins; Quipazine; Reboxetine; Serotonin	2012
Diminished conditioned responding to the nicotine stimulus by antidepressant drugs with differing specificity for the serotonin and norepinephrine transporter. Pharmacology, biochemistry, and behavior, 2012, Volume: 100, Issue:3 Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Generalization, Response; Imipramine; Male; Morpholines; Nicotine; Nicotinic Agonists; Norepinephrine Plasma Membrane Transport Proteins; Random Allocation; Rats; Rats, Sprague-Dawley; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Tobacco Use Disorder	2012
The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia, 2012, Volume: 53, Issue:5 Topics: Animals; Antidepressive Agents; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Kainic Acid; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Seizures; Status Epilepticus; Time Factors; Treatment Outcome; Video Recording	2012
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation. Pharmacological reports : PR, 2012, Volume: 64, Issue:4 Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Blood Coagulation; Blood Platelets; Citalopram; Cyclohexanols; Female; Fibrinogen; Humans; Male; Middle Aged; Morpholines; Norepinephrine; Platelet Adhesiveness; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Venlafaxine Hydrochloride; Young Adult	2012
GPR39 up-regulation after selective antidepressants. Neurochemistry international, 2013, Volume: 62, Issue:7 Topics: Animals; Antidepressive Agents; Brain; Bupropion; Citalopram; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptors, G-Protein-Coupled; Up-Regulation; Zinc	2013
Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test. Pharmacology, biochemistry, and behavior, 2013, Volume: 110 Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Citalopram; Dose-Response Relationship, Drug; Female; Morpholines; Rats; Reboxetine; Selective Serotonin Reuptake Inhibitors; Swimming	2013
Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications. Journal of molecular neuroscience : MN, 2014, Volume: 52, Issue:4 Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Citalopram; Clomipramine; Cyclohexanols; Desipramine; Drug Interactions; Fluvoxamine; Male; Methadone; Mice; Mice, Inbred ICR; Morpholines; Nociception; Pain Threshold; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride	2014
Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. Pharmacological reports : PR, 2013, Volume: 65, Issue:4 Topics: 2-Amino-5-phosphonovalerate; Animals; Antidepressive Agents; Citalopram; Cyclopropanes; Imipramine; Immobility Response, Tonic; Male; Mice; Milnacipran; Morpholines; Motor Activity; N-Methylaspartate; Oxazines; Quinoxalines; Reboxetine; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate	2013
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy? Psychopharmacology, 2014, Volume: 231, Issue:9 Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors	2014
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. Neuropharmacology, 2014, Volume: 84 Topics: Animals; Antidepressive Agents; Blotting, Western; Brain; Cerebral Cortex; Citalopram; Excitatory Amino Acid Antagonists; Hippocampus; Imipramine; Male; Moclobemide; Morpholines; Pyridines; Radioligand Assay; Rats, Wistar; Reboxetine; Receptor, Metabotropic Glutamate 5; Thiazoles; Tritium	2014
Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial. Journal of affective disorders, 2014, Volume: 163 Topics: Adult; Antidepressive Agents; Citalopram; Depression; Female; Humans; Linear Models; Male; Middle Aged; Morpholines; Prognosis; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Reboxetine; Treatment Outcome	2014
Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology, 2014, Volume: 86 Topics: Amino Acids; Animals; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Down-Regulation; Female; Humans; Ketanserin; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Prefrontal Cortex; Radioligand Assay; Rats, Sprague-Dawley; Reboxetine; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; RNA, Messenger; Tritium; Xanthenes	2014
Chronic but not acute antidepresant treatment alters serum zinc/copper ratio under pathological/zinc-deficient conditions in mice. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2014, Volume: 65, Issue:5 Topics: Animals; Antidepressive Agents; Bupropion; Citalopram; Copper; Depression; Disease Models, Animal; Imipramine; Male; Mice; Morpholines; Reboxetine; Sodium Chloride; Zinc	2014
Study of antidepressant drugs in GPR39 (zinc receptor⁻/⁻) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists. Behavioural brain research, 2015, Volume: 287 Topics: Animals; Antidepressive Agents; Citalopram; Depression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Imipramine; Ketamine; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Motor Activity; Psychological Tests; Reboxetine; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Swimming	2015
Up-regulation of the GPR39 Zn2+-sensing receptor and CREB/BDNF/TrkB pathway after chronic but not acute antidepressant treatment in the frontal cortex of zinc-deficient mice. Pharmacological reports : PR, 2015, Volume: 67, Issue:6 Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Bupropion; Citalopram; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Drug Administration Schedule; Frontal Lobe; Imipramine; Male; Mice; Morpholines; Reboxetine; Receptor, trkB; Receptors, G-Protein-Coupled; Signal Transduction; Up-Regulation; Zinc	2015
Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration. Pharmacology, biochemistry, and behavior, 2016, Volume: 144 Topics: Animals; Behavior, Animal; Citalopram; Depression; Interleukin-10; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Morpholines; Reboxetine; Tumor Necrosis Factor-alpha	2016
The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram. Behavioural brain research, 2016, 07-15, Volume: 308 Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Electromyography; Locomotion; Mice; Mice, Inbred C57BL; Mice, Transgenic; Morpholines; Narcolepsy; Orexins; Reboxetine; Selective Serotonin Reuptake Inhibitors; Time Factors	2016
The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test. Progress in neuro-psychopharmacology & biological psychiatry, 2017, 10-03, Volume: 79, Issue:Pt B Topics: alpha-Methyltyrosine; Animals; Antidepressive Agents; Citalopram; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Membrane Transport Modulators; Mice, Inbred C57BL; Morpholines; Motor Activity; Norepinephrine; Reboxetine; Scopolamine; Serotonin	2017
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis. BMJ open, 2017, Aug-03, Volume: 7, Issue:8 Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome	2017
Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters. ChemMedChem, 2018, 03-06, Volume: 13, Issue:5 Topics: Benzhydryl Compounds; Binding Sites; Chromatography, Liquid; Citalopram; Dopamine Plasma Membrane Transport Proteins; Humans; Molecular Structure; Norepinephrine Plasma Membrane Transport Proteins; Piperidines; Reboxetine; Serotonin Plasma Membrane Transport Proteins; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2018
Development and validation of an LC-ESI-MS/MS method for the quantification of D-84, reboxetine and citalopram for their use in MS Binding Assays addressing the monoamine transporters hDAT, hSERT and hNET. Biomedical chromatography : BMC, 2018, Volume: 32, Issue:7 Topics: Animals; Benzhydryl Compounds; Chromatography, Liquid; Citalopram; Humans; Morpholines; Piperidines; Protein Binding; Reboxetine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Symporters; Tandem Mass Spectrometry	2018
DPCPX, a selective adenosine A1 receptor antagonist, enhances the antidepressant-like effects of imipramine, escitalopram, and reboxetine in mice behavioral tests. Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:12 Topics: Adenosine A1 Receptor Antagonists; Animals; Antidepressive Agents; Brain; Citalopram; Depression; Drug Interactions; Drug Therapy, Combination; Hindlimb Suspension; Imipramine; Male; Mice; Motor Activity; Reboxetine; Serotonin Antagonists; Xanthines	2018
Effects of noradrenergic and serotonergic systems on risk-based decision-making and center arena activity in open field in rats. European journal of pharmacology, 2018, Dec-15, Volume: 841 Topics: Animals; Behavior, Animal; Choice Behavior; Citalopram; Decision Making; Dexmedetomidine; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Reboxetine; Reward; Risk-Taking; Serotonin	2018
Effect of monoamine reuptake inhibition and α Epilepsia, 2019, Volume: 60, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Citalopram; Duloxetine Hydrochloride; Electroshock; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Reboxetine; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Sudden Unexpected Death in Epilepsy	2019
Antidepressants Differentially Regulate Intracellular Signaling from α1-Adrenergic Receptor Subtypes In Vitro. International journal of molecular sciences, 2021, May-01, Volume: 22, Issue:9 Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Fluoxetine; Gene Expression Regulation; Humans; Imipramine; Mianserin; Mice; PC12 Cells; Rats; Reboxetine; Receptors, Adrenergic, alpha-1; Signal Transduction	2021